Sulfamethoxazole 80 mg/mL - search results

United States - English - NLM (National Library of Medicine)

sulfamethoxazole and trimethoprim ds- sulfamethoxazole and trimethoprim tablet

advanced rx pharmacy of tennessee, llc - trimethoprim (unii: an164j8y0x) (trimethoprim - unii:an164j8y0x), sulfamethoxazole (unii: je42381tnv) (sulfamethoxazole - unii:je42381tnv) - indications and usage to reduce the development of drug-resistant bacteria and maintain the effectiveness of sulfamethoxazole and trimethoprim tablets and other antibacterial drugs, sulfamethoxazole and trimethoprim tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to empiric selection of therapy. urinary tract infections: for the treatment of urinary tract infections due to susceptible strains of the following organisms: escherichia coli, klebsiella species, enterobacter species, morganella morganii, proteus mirabilis and proteus vulgaris. it is recommended that initial episodes of uncomplicated urinary tract infections be treated with a single effective antibacterial agent rather than the combination. a

United States - English - NLM (National Library of Medicine)

sulfamethoxazole and trimethoprim ds- sulfamethoxazole and trimethoprim tablet

Australia - English - Department of Health (Therapeutic Goods Administration)

dbl sulfamethoxazole 400 mg and trimethoprim 80 mg/5 ml concentrated injection ampoule

pfizer australia pty ltd - trimethoprim, quantity: 16 mg/ml; sulfamethoxazole, quantity: 80 mg/ml - injection, concentrated - excipient ingredients: sodium metabisulfite; propylene glycol; ethanol; diethanolamine; sodium hydroxide; water for injections; hydrochloric acid - indications as at 31 october 2003 :parenteral administration of sulfamethoxazole/trimethoprim is indicated where oral dosage is not desirable or practical, e.g. pre- and post-operative infections associated with surgery, trauma or gynaecology; septicaemia and other infections due to sensitive organisms such as typhoid and paratyphoid.

Ireland - English - HPRA (Health Products Regulatory Authority)

septrin 80 mg/400 mg per ampoule, concentrate for solution for infusion

aspen pharma trading limited - sulfamethoxazole; trimethoprim - concentrate for solution for infusion - 80 mg/400 mg/5ml - sulfamethoxazole and trimethoprim

United States - English - NLM (National Library of Medicine)